Drug Research

Croda Pharma has introduced a critical range of new bioprocessing detergents optimised for viral inactivation and cell lysis. The company’s new product range, Virodex™, offers an answer to the key market need for replacing the popular, but now banned,...

The parenteral drug manufacturing process is anchored by the Supply Chain. The impact of COVID-19 has influenced both positively and negatively the production of contemporary parenteral drugs. Many manufacturers have structured their systems around the lean Just-In-Time (JIT) production...

Lonza has launched the Nebula® Absorbance Reader, a new absorbance microplate reader which joins the company’s portfolio of optimized instruments for streamlined endotoxin and pyrogen testing. Pharmaceutical quality control (QC) laboratories worldwide rely on the traditional absorbance-based Limulus amebocyte lysate (LAL) and Tachypleus amebocyte...

As per insights, a significant increase in the small molecule active pharmaceutical ingredient (API) market has been projected, estimating it to be valued at approximately $284.7 billion by 2032, compared to $162.8 billion in 2022. A compound annual growth...

The healthcare industry is responsible for 4.4% of all greenhouse gas emissions and faces significant challenges in its supply chain, resulting in $35 billion worth of wasted products each year. Startups have emerged as powerful agents of change, leveraging...

Overseeing a pharmaceutical supply chain and ensuring its efficiency is a complex and collaborative endeavor. The process commences with sourcing raw materials, including chemicals and ingredients, which are used to manufacture drugs. These drugs undergo stringent quality checks, formulation,...

In the late 1950s and 1960s, thalidomide, a drug given to pregnant women to alleviate morning sickness, caused a tragic outcome. Over 12,000 babies were born with severe malformations, like shortened limbs, due to the drug's side effects. These...